Related Experiment Video
Updated: Sep 10, 2025

07:44
Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
Published on: March 25, 2022
5.9K
Endobiliary Radiofrequency Ablation for Hepato-Biliary Diseases: A Narrative Review
Tawfik Khoury1,2, Wisam Sbeit1,2, Andrea Lisotti3
1Department of Gastroenterology, Galilee Medical Center, Nahariya 22100, Israel.
Diseases (Basel, Switzerland)
|August 27, 2025
Summary
Endobiliary radiofrequency ablation (RFA) improves stent patency and survival for malignant biliary obstruction. This review covers RFA indications, safety, and efficacy for biliary diseases.
Area of Science:
- Gastroenterology and Hepatology
- Interventional Endoscopy
- Oncology
Background:
- Malignant biliary diseases present significant therapeutic challenges with poor prognoses.
- Current curative treatments for malignant biliary obstruction (MBO) offer limited patient response.
- Endobiliary radiofrequency ablation (RFA) is emerging as a valuable adjunct therapy for MBO.
Purpose of the Study:
- To review the indications, procedural techniques, safety, and comparative efficacy of endobiliary RFA.
- To provide a comprehensive understanding of RFA's clinical applications in biliary diseases.
- To explore the future implications of endobiliary RFA for MBO management.
Main Methods:
- Comprehensive literature review of endobiliary RFA in malignant biliary diseases.
- Analysis of procedural details, safety profiles, and patient outcomes.
- Comparative efficacy assessment of RFA combined with stenting versus stenting alone.
Main Results:
- Endobiliary RFA is technically feasible with a high safety profile.
- RFA significantly enhances biliary stent patency.
- Combined RFA and stenting may improve survival in MBO patients compared to stenting alone.
- RFA shows promise for treating intraductal ampullary tumors.
Conclusions:
- Endobiliary RFA demonstrates a beneficial therapeutic effect for biliary strictures.
- RFA has a potential positive impact on patient outcomes and survival in malignant biliary diseases.

